MoonLake Immunotherapeutics MLTX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's change in other assets?
- MoonLake Immunotherapeutics (MLTX) reported change in other assets of $749K in Q1 2026.
- How has MoonLake Immunotherapeutics's change in other assets changed year-over-year?
- MoonLake Immunotherapeutics's change in other assets decreased by 55.9% year-over-year, from $1.7M to $749K.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.